Methods and unit dose formulations for the inhalation...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 9/12 (2006.01) A61K 31/7036 (2006.01) A61K 51/04 (2006.01)

Patent

CA 2447600

A patient suffering from an endobronchial infection is treated by administering to the patient for inhalation a dose of less than about 4.0 ml of a nebulized aerosol formulation comprising from about 60 to about 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, in a physiologically acceptable carrier in a time period of less than about 10 minutes. Unit dose devices for storage and delivery of the aminoglycoside antibiotic formulations are also provided.

Selon la présente invention, un patient souffrant d'une infection endobronchique est traité au moyen de l'administration par inhalation d'une dose inférieure à environ 4,0 ml d'une formulation sous forme d'aérosol comprenant entre environ 60 et 200 mg/ml d'un aminoside, tel que la tobramycine, dans un excipient physiologiquement acceptable pendant une durée inférieure à environ 10 minutes. Cette invention porte sur des dispositifs de dose unitaire permettant le stockage et l'administration de formulations d'aminosides.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and unit dose formulations for the inhalation... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and unit dose formulations for the inhalation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and unit dose formulations for the inhalation... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1617513

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.